| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10a51944d9b1ea4e3ed39e5d3758ca70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1fa288ad10ba8432a238c088d20c3ce3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_53ac89f36830314832dd7c0c8bb4f61c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6e29526f284c0155fd79806c9dd5a1c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2f617ad6dd59ad450ae8a54343dc733f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aefd188b0ab5a61bd88b81cfa2fc409e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-172
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2008-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_374d858eb7aba855ab947284cbb88be2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69ab157b396bd74fa5baa4a6b18576e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4158786b635569b13bd5f57e753bf20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2291803d6fb9fa2e5f4cde1f6612a09e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25bc264ab0f5dbd93db7923d5184dd55 |
| publicationDate |
2008-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2008121788-A2 |
| titleOfInvention |
Haplotypes of lipoprotein lipase, visceral adiposity and fasting insulin levels |
| abstract |
The invention provides various methods of diagnosing susceptibility to and/or protection against conditions associated with insulin resistance syndrome in an individual. In one embodiment, the present invention provides a method of determining protection against insulin resistance syndrome in an individual by determining the presence of haplotype (1) at the LPL locus. In another embodiment, the present invention provides a method of determining susceptibility to insulin resistance syndrome in an individual by determining the presence of haplotype (2) at the LPL locus and/or haplotype (4) at the LPL locus. In another embodiment, the individual is Hispanic. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8178294-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010051483-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012088245-A1 |
| priorityDate |
2007-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |